Skip to content
Sunday 13 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
+0.78%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 05 January 2021 5:33 pm

World Bank: Delays to vaccine rollout will dent recovery

By: Angharad Carrick

Add as a preferred source on Google

Global economic output is expected to increase this year but it is largely dependent on the success of a vaccine rollout, the World Bank has warned. 

The lender forecast that global GDP will expand four per cent in 2021 but will remain well below pre-pandemic projections due to a surge in new cases. 

The “heightened level of uncertainty” means that any delay to the rollout could risk more than halving 20201’s growth rate. 

Since autumn there has been a slow uptick in the number of cases which has jumped since the discovery of a mutant strain, first discovered in the UK. 

The World Bank warned that further downside risks, including the further resurgence of the virus and more severe effects on output would dent the recovery. This could trigger a wave of bankruptcies and banking balance sheets taking a further hit. 

The multilateral lender has even warned that prolonged economic weakness could see governments unable to continue providing financial support, which has proved a lifeline for millions of businesses. 

In Europe and Central Asia, regional GDP is estimated to have contracted 2.9 per cent in 2020 with nearly all economies in recession. 

And the World Bank is forecasting just a moderate 3.3 per cent growth in 2021 as a resurgence in cases causes disruption to output. 

“The outlook is predicated on the distribution of an effective vaccine in early in 2021 in advanced economies and major emerging market and developing economies,” it said.

There was widespread optimism at the end of 2020 as the Pfizer/Biontech and Oxford/Astrazeneca vaccines reported high efficacy rates, but the logistics of mass rollout have proved a barrier.

France has vaccinated just 350 people while Germany has been slow to obtain enough doses. In a Downing Street press conference, the Prime Minister announced 1.3m elderly and vulnerable people in the UK have been vaccinated.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics
  • News

Categories

  • Business
  • Economics

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Badger Beer maker Hall & Woodhouse doubles profit ahead of tie-up with James May

  • Four interest rate hikes loom despite surprise economic growth

  • Primark sales slip as owner dresses up retailer for demerger

  • As it happened: FTSE 100 rallies as economy beats forecasts; oil falls back

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • UK fintech Allica Bank looks to crack European market

    Fintech
    London rail infrastructure and urban development captured in partnership with Allica Bank, showcasing modern transportatio...
  • Citi Unveils Custody+: A Suite of Near- and Real-time Custody Solutions to Meet Always-On Industry Demand

    Business Wire
  • Gym Group upgrades outlook as Gen-Z shrugs off heatwave and World Cup

    Leisure
    Man in The Gym Group uniform smiling at a woman on an exercise bike.
  • Manchester billionaire tables £583m offer for property developer Harworth

    Property
    Harworth Group building exterior with a brick facade and prominent entrance under a blue sky
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Just Eat takes UK AI ordering tool across Europe

    Tech
    Private equity giant Prosus will acquire Just Eat Takeaway.com
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook